Seunghwan Choi Selected Research

Hypertension (High Blood Pressure)

12/2018

NF-κB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seunghwan Choi Research Topics

Disease

4	Pre-Eclampsia (Preeclampsia) 01/2020 - 01/2017
3	Inflammation (Inflammations) 10/2022 - 01/2018
3	Hyperalgesia 01/2019 - 05/2017
2	Neuroinflammatory Diseases 01/2024 - 10/2023
2	Glaucoma 01/2024 - 10/2023
2	Vascular Diseases (Vascular Disease) 01/2020 - 01/2018
2	Neoplasms (Cancer) 12/2019 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 12/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Disease Progression 10/2023
1	Autism Spectrum Disorder 01/2023
1	Obesity 10/2022
1	Cognitive Dysfunction 01/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021
1	Retinal Diseases 02/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Atherosclerosis 01/2019
1	Choroidal Neovascularization 01/2019
1	Vascular Remodeling 12/2018
1	Hypertension (High Blood Pressure) 12/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Shock 01/2018
1	Neuralgia (Stump Neuralgia) 12/2017
1	Pain (Aches) 12/2017
1	Pregnancy Complications 01/2017

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 01/2024 - 01/2019
3	arginyl-leucyl-tyrosyl-glutamic acidIBA 02/2021 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 05/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 01/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2021 - 12/2019
2	Therapeutic UsesIBA 02/2021 - 12/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 12/2019
2	AcetoneIBA 01/2019 - 12/2017
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2017
2	CytokinesIBA 12/2018 - 01/2018
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2018 - 01/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2017 - 05/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2023
1	Toll-Like Receptor 4IBA 10/2023
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2023
1	CholesterolIBA 10/2023
1	Interleukin-1 (Interleukin 1)IBA 10/2023
1	CateninsIBA 01/2023
1	Amino Acids FDA Link 10/2022
1	PlasminogenIBA 02/2021
1	erucylphosphocholineIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2019
1	Bee Venoms (Bee Venom)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Melitten (Melittin)IBA 01/2019
1	Messenger RNA (mRNA)IBA 12/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	EndotoxinsIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 12/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017

Therapy/Procedure

1	Intravitreal Injections 10/2023
1	Vagus Nerve Stimulation 01/2022
1	Acupuncture Points (Acupuncture Point) 01/2019
1	Drug Therapy (Chemotherapy) 12/2017